Leishmanicidal effect of Spiranthera odoratíssima (Rutaceae) and its isolated alkaloid skimmianine occurs by a nitric oxide dependent mechanism

SUMMARY Leishmaniasis is one of the neglected diseases. High cost, systemic toxicity, and diminished efficacy due to development of resistance by the parasites has a negative impact on the current treatment options. Thus, the search for a new, effective and safer anti-leishmanial drug becomes of paramount importance. Compounds derived from natural products may be a better and cheaper source in this regard. This study evaluated the in vitro anti-leishmanial activity of Spiranthera odoratíssima (Rutaceae) fractions and isolated compounds, using promastigote and amastigote forms of different Leishmania species. J774 A.1 macrophage was used as the parasite host cell for the in vitro assays. Evaluations of cytoxicity, nitric oxide (NO), interleukin-10 and in silico analysis were carried out. In vitro experiments showed that the fruit hexanic fraction (Fhf) and its alkaloid skimmianine (Skm) have a significant (P<0·001) effect against L. braziliensis. This anti-L. braziliensis activity of Fhf and Skm was due to increased production of NO and attenuation of IL-10 production in the macrophages at concentrations ranging from 1·6 to 40·0 μg/ml. The in silico assay demonstrated significant interaction between Skm and amino acid residues of NOS2. Skm is thus a promising drug candidate for L. braziliensis due to its potent immunomodulatory activity.

[1]  M. Chatterjee,et al.  Plant derived therapeutics for the treatment of Leishmaniasis. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[2]  C. Barbiéri,et al.  Neutrophils Reduce the Parasite Burden in Leishmania (Leishmania) amazonensis-Infected Macrophages , 2010, PloS one.

[3]  L. Espindola,et al.  Investigation of plant extracts in traditional medicine of the Brazilian Cerrado against protozoans and yeasts. , 2010, Journal of ethnopharmacology.

[4]  M. Pinart,et al.  Designing and reporting clinical trials on treatments for cutaneous leishmaniasis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Â. Pinto,et al.  Leishmanicidal activity of Himatanthus sucuuba latex against Leishmania amazonensis. , 2010, Parasitology international.

[6]  V. Dubey,et al.  Rational Approaches for Drug Designing Against Leishmaniasis , 2010, Applied biochemistry and biotechnology.

[7]  O. Bueno,et al.  Activities of extracts and compounds from Spiranthera odoratissima St. Hil. (Rutaceae) in leaf-cutting ants and their symbiotic fungus , 2010 .

[8]  R. Singh,et al.  Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents. , 2009, Mini reviews in medicinal chemistry.

[9]  B. Rossi-Bergmann,et al.  Immunomodulatory pretreatment with Kalanchoe pinnata extract and its quercitrin flavonoid effectively protects mice against fatal anaphylactic shock. , 2008, International immunopharmacology.

[10]  J. Tainer,et al.  Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase , 2008, Nature chemical biology.

[11]  R. Kumar,et al.  Antileishmanial activity in vitro and in vivo of constituents of sea cucumber Actinopyga lecanora , 2008, Parasitology Research.

[12]  T. Efferth,et al.  Leishmaniasis: drug resistance and natural products (review). , 2008, International journal of molecular medicine.

[13]  Lidia M. Lima,et al.  Química Medicinal Moderna: desafios e contribuição brasileira , 2007 .

[14]  R. Peeling,et al.  Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? , 2007, Nature Reviews Microbiology.

[15]  P. Tripathi Nitric oxide and immune response. , 2007, Indian journal of biochemistry & biophysics.

[16]  R. Pijnenborg,et al.  The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. , 2007, Human reproduction.

[17]  M. Kaiser,et al.  In vitro antiprotozoal activities and cytotoxicity of some selected Cameroonian medicinal plants. , 2007, Journal of ethnopharmacology.

[18]  K. Siems,et al.  Plants traditionally used against malaria: phytochemical and pharmacological investigation of Momordica foetida , 2007 .

[19]  René Thomsen,et al.  MolDock: a new technique for high-accuracy molecular docking. , 2006, Journal of medicinal chemistry.

[20]  N. Sen,et al.  Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics. , 2006, The Indian journal of medical research.

[21]  M. N. Muscará,et al.  Óxido nítrico: propriedades e potenciais usos terapêuticos , 2005 .

[22]  J. Ellena,et al.  Limonoids from Spiranthera odoratissima St. Hil , 2005 .

[23]  Mingliang Ye,et al.  Characterization of small-molecule–biomacromolecule interactions: From simple to complex , 2005 .

[24]  W. de Souza,et al.  Antileishmanial Activity of Parthenolide, a Sesquiterpene Lactone Isolated from Tanacetum parthenium , 2005, Antimicrobial Agents and Chemotherapy.

[25]  M N Muscara,et al.  Nitric Oxide: Properties And Therapeutic Use [Óxido Nítrico: Propriedades E Potenciais Usos Terapêuticos] , 2005 .

[26]  E. A. Costa,et al.  Analgesic and anti‐inflammatory activity of the ethanolic extract from Spiranthera odoratissima A. St. Hillaire (Manacá) roots , 2004, Phytotherapy research : PTR.

[27]  Seaver,et al.  Nitric oxide as a secretory product of mammalian cells , 2004 .

[28]  T. Souto-Padrón,et al.  Antileishmanial Activity of a Linalool-Rich Essential Oil from Croton cajucara , 2003, Antimicrobial Agents and Chemotherapy.

[29]  H. Castro-Faria-Neto,et al.  Cissampelos sympodialis Eichl (Menispermaceae) leaf extract induces interleukin-10-dependent inhibition of Trypanosoma cruzi killing by macrophages. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[30]  Christian Bogdan,et al.  Nitric oxide and the immune response , 2001, Nature Immunology.

[31]  L. Brunet Nitric oxide in parasitic infections. , 2001, International immunopharmacology.

[32]  T. van der Poll,et al.  Proinflammatory Effects of IL-10 During Human Endotoxemia1 , 2000, The Journal of Immunology.

[33]  P. Waterman The chemical systematics of alkaloids: A review emphasising the contribution of Robert Hegnauer , 1999 .

[34]  D. Sereno,et al.  Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro , 1997, Parasitology Research.

[35]  J. Streit,et al.  Visceral Leishmaniasis , 2011 .

[36]  V. Muñoz,et al.  Effect of some bisbenzylisoquinoline alkaloids on American Leishmania sp. in BALB/c mice , 1993 .

[37]  Mohamed,et al.  Interleukin 10 production correlates with pathology in human Leishmania donovani infections. , 1993, The Journal of clinical investigation.

[38]  A. Sher,et al.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.